Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Blankenstein

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|December 12, 2018
Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regressionLucia Poncette, Xiaojing Chen, Felix Km Lorenz, et al.
Frontiers in Immunology|February 11, 2025
T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapyMeng-Tung Hsu, Gerald Willimsky, Leo Hansmann, et al.
International Journal of Cancer|February 9, 2005
Tumor-induced antibodies resemble the response to tissue damageSusanne Preiss, Thomas Kammertoens, Christoph Lampert, et al.
The Journal of Clinical Investigation|March 5, 2013
Virus-induced hepatocellular carcinomas cause antigen-specific local toleranceGerald Willimsky, Karin Schmidt, Christoph Loddenkemper, et al.
Nature Reviews. Cancer|March 2, 2012
The determinants of tumour immunogenicityThomas Blankenstein, Pierre G Coulie, Eli Gilboa, et al.
International Journal of Cancer|January 4, 2012
B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin)Thomas Kammertoens, Zhihai Qin, Dana Briesemeister, et al.
Thyroid : Official Journal of the American Thyroid Association|November 19, 2020
Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient BloodHeidrun Degen, Ioannis Gavvovidis, Thomas Blankenstein, et al.
MMW Fortschritte Der Medizin|February 9, 2018
[Changes to cervical cancer screening in Germany]Teresa Starrach, Julia Gallwas, Thomas Blankenstein, et al.
Plos One|July 23, 2016
Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host CellsKatrin Deiser, Diana Stoycheva, Ute Bank, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2008
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transferElisa Kieback, Jehad Charo, Daniel Sommermeyer, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|December 12, 2018
Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regressionLucia Poncette, Xiaojing Chen, Felix Km Lorenz, et al.
Frontiers in Immunology|February 11, 2025
T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapyMeng-Tung Hsu, Gerald Willimsky, Leo Hansmann, et al.
International Journal of Cancer|February 9, 2005
Tumor-induced antibodies resemble the response to tissue damageSusanne Preiss, Thomas Kammertoens, Christoph Lampert, et al.
The Journal of Clinical Investigation|March 5, 2013
Virus-induced hepatocellular carcinomas cause antigen-specific local toleranceGerald Willimsky, Karin Schmidt, Christoph Loddenkemper, et al.
Nature Reviews. Cancer|March 2, 2012
The determinants of tumour immunogenicityThomas Blankenstein, Pierre G Coulie, Eli Gilboa, et al.
International Journal of Cancer|January 4, 2012
B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin)Thomas Kammertoens, Zhihai Qin, Dana Briesemeister, et al.
Thyroid : Official Journal of the American Thyroid Association|November 19, 2020
Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient BloodHeidrun Degen, Ioannis Gavvovidis, Thomas Blankenstein, et al.
MMW Fortschritte Der Medizin|February 9, 2018
[Changes to cervical cancer screening in Germany]Teresa Starrach, Julia Gallwas, Thomas Blankenstein, et al.
Plos One|July 23, 2016
Interleukin-7 Modulates Anti-Tumor CD8+ T Cell Responses via Its Action on Host CellsKatrin Deiser, Diana Stoycheva, Ute Bank, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2008
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transferElisa Kieback, Jehad Charo, Daniel Sommermeyer, et al.
Pageof 14